Pharmaceutical Project of the Industrial Core Area of Qingdao International Academician Park

  • Budget:8billion
    Cooperation Mode:Cooperation
  • Industry:Healthcare & elderly care
    Jurisdiction:Qingdao

Land Quota

The relevant land quota has been obtained.

Target Investors

Leading enterprises in the biological medicine industry, Top 500 enterprises at home and abroad, emerging enterprises, unicorn enterprises, etc.

Market Potential

To nurture new economic growth drivers for the region, continuously release momentum and play an active role in promoting industrial transformation and upgrading as well as high-quality development, the project is set to attract international first-class laboratories for the research, development, testing and certification of biomedicine technologies and gather a cluster of biomedicine enterprises.

Advantages

1. The industrial carrying needs are fully considered. The inner space of the buildings is reserved according to large space framework design, and can be flexibly combined based on the needs of enterprises. 2. The infrastructure is complete and fully considers the characteristics of biomedicine industry. Facilities such as professional ventilation, energy, sewage treatment and utility tunnel are installed. 3. The utilization of underground space is a highlight. The project develops such functions as business convenience, living facilities, intelligent parking and intelligent warehousing underground, and provides more space for production, landscaping and leisure. 4. Supporting public industry service platform can provide internationally leading professional services such as research and development, manufacturing, testing and certification.

Preferential Policies

The park will grant preferential policies in terms of office space and local financial contribution for enterprises in the park based on their project investment, operating income, scientific and technological advancement and predicted tax payment.

Investment Requirements

It currently sets sights on enterprises from sectors related to biomedicine, such as the import and export of APIs, preparation production, medicine sales and distribution, relevant equipment and consumables, supporting service facilities and capital oper

Contact

Xu Jicheng      15253285285